19 · 09 · 18 - Our clients - ABG IP
Spherium Biomed announces positive outcome of Cyclatop’s (SP14019) clinical trial showing that the product is safe and efficacious for the treatment of Atopic Dermatitis in adults and infants
18 · 09 · 18 - About Us - ABG IP
ABG IP in PTMG (Pharmaceutical Trade Marks Group)
05 · 09 · 18 - About Us - ABG IP
ABG IP participates in the EUIPO report “The Baseline of Trade Secrets Litigation in the EU”
04 · 09 · 18 - About Us - ABG IP
ABG IP Seminar “IP Euskadi”
23 · 08 · 18 - About Us - ABG IP
ABG IP launches its Counterfeit Goods’ Customs Seizure Service
27 · 07 · 18 - About Us - ABG IP
New European Patent Attorney at ABG IP
25 · 07 · 18 - About Us - ABG IP
ABG IP in the “EMBL Career Day”
16 · 07 · 18 - About Us - ABG IP
ABG IP at Biospain 2018
12 · 07 · 18 - About Us - ABG IP
European Patent Law Course 2018
03 · 07 · 18 - IP News - ABG IP
UPC Agreement ruled unconstitutional in Hungary